Pfizer and Merck Receive Key Regulatory Approvals - Presented by: The Aol. On Network

Shares of Pfizer and Merck are in the spotlight on Wednesday after both companies won some key federal regulatory approvals. Pfizer received the backing of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices. The group gave Pfizer's Prevnar 13 vaccine approval for people ages 65 and older. Also, watch shares of Merck after it received approval to sell Belsomra, its treatment for insomnia.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
F $ 13.78 0.62 ▼ 4.31%
MSFT $ 45.85 0.83 ▲ 1.84%
PBR $ 13.075 0.97 ▲ 7.97%
AAPL $ 104.94 0.11 ▲ 0.10%
VALE $ 11.29 0.46 ▲ 4.25%
P $ 19.49 3.63 ▼ 15.70%
BAC $ 16.655 0.06 ▲ 0.33%
QQQ $ 98.265 0.45 ▲ 0.45%

As of 10/24/2014, 12:24 PM
More Most Active